Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM Conditioning for Lymphoma Patients With High Risk of CNS Relapse
NCT07481669Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in non-Hodgkin lymphoma (NHL), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Mar 2026; status: recruiting.
02
Drugs
thiotepa
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT07481669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07481669.